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Abstract
Background: Integrins are required for normal muscle differentiation and disruptions in integrin
signaling result in human muscle disease. The intracellular components that regulate integrin
function during myogenesis are poorly understood. Unc-112 is an integrin-associated protein
required for muscle development in C. elegans. To better understand the intracellular effectors of
integrin signaling in muscle, we examined the mammalian homolog of Unc-112, kindlin-2.
Results: Kindlin-2 expression is upregulated during differentiation and highly enriched at sites of
integrin localization. RNAi knockdown of kindlin-2 in C2C12 cells results in significant
abnormalities during the early stages of myogenesis. Specifically, differentiating myocytes lacking
kindlin-2 are unable to elongate and fail to fuse into multinucleated myotubes. These changes are
correlated with decreased cell substratum adhesion and increased cell motility. They are also
associated with redistribution of a known kindlin-2 binding partner, integrin linked kinase (ILK), to
the membrane insoluble subcellular fraction.
Conclusion: In all, our study reveals kindlin-2 as a novel integrin adaptor protein important for
muscle differentiation, and identifies it particularly as a critical regulator of myocyte elongation.
Background
Skeletal muscle is a highly specialized tissue composed of
multinucleated myotubes. The formation of myotubes
from mononucleated precursor myoblasts via myogenesis
is a complex, highly regulated process requiring both
genetic and morphologic changes[1,2]. Understanding
the molecular components of myogenesis is of high bio-
logic and clinical importance, as the differentiation pro-
gram is employed not only during development but also
in the muscle regeneration response to injury[3]. In addi-
tion, several myopathies in humans are the result of aber-
rant muscle differentiation[4].
Integrin receptor mediated adhesion and signaling is
required for proper myogenesis[5]. Specifically, integrin
function has been demonstrated both in vitro and in vivo
to be required for myoblast fusion and for sarcomerogen-
esis[6,7]. In addition, integrins are implicated in many
other aspects of myogenesis, especially those related to
the morphologic changes that accompany the differentia-
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tion process. The importance of integrins in skeletal mus-
cle is underscored by the association between integrin
abnormalities (both direct and indirect) and the patho-
genesis of muscular dystrophy[8,9].
Numerous cytosolic effector molecules localize to integrin
junctions and are associated with fundamental integrin-
regulated processes like cell adhesion and cell migra-
tion[10]. However, the specific effectors that are responsi-
ble during myogenesis for transducing integrin signals,
and thus for regulating integrin function in muscle, are
not well established. Exceptions are integrin-linked kinase
(ILK), which likely has multiple important roles[11,12],
filamin-C, which is important for myoblast fusion[13],
and focal adhesion kinase (FAK), which participates in the
regulation of costamerogenesis[14].
We are interested in identifying other integrin-associated
cytoplasmic adaptors important for myogenesis. One
interesting potential candidate is kindlin-2/mig-2, a
FERM and PH domain-containing protein that localizes to
focal contacts and directly binds to the tail domain of β1
integrin[15,16]. Kindlin-2 is a member of the kindlin
family of proteins[17]. These proteins are so named
because of the association between kindlin-1 mutations
and Kindler Syndrome, an epidermal blistering/skin fra-
gility syndrome[18]. The kindlin family represents the
vertebrate homologs of unc-112, a C. elegans protein
implicated in integrin signal transduction during myogen-
esis[19]. Unc-112 specifically functions in the establish-
ment of the linkage between the nematode integrins and
the sarcomeric protein complex. Loss of unc-112 results in
severe abnormalities in the organization and stability of
the C. elegans body wall musculature.
Because of the important role of unc-112 in regulating
integrin dependent aspects of muscle development in C.
elegans, it is likely that kindlins are critical for vertebrate
myogenesis. Kindlin-2 function is of particular interest as
it is the only unc-112 homolog appreciably expressed in
muscle in vivo[17,20]. Our previous work has revealed an
essential role for kindlin-2 in vertebrate development[20].
Gene targeting in the mouse results in early embryonic
lethality, and gene knockdown in the zebrafish causes
abnormalities in multiple organ systems. Kindlin-2 loss in
the zebrafish produces a severe cardiac and skeletal myop-
athy, and demonstrates a specific requirement for kindlin-
2 in mediating the attachment of myofibrils to the sarco-
lemmal membrane.
In the present study, we focused on the role of kindlin-2
during the early stages of myogenesis. To test kindlin-2's
function, we utilized the well-characterized C2C12 cell
culture model system. C2C12 cells, when induced by
serum withdrawal, go through a series of developmental
stages that eventually produce a multinucleated myotube
capable of spontaneous contraction. We first defined
kindlin-2 expression during C2C12 myogenesis, and
found it upregulated during the differentiation stage just
prior to myoblast fusion and characterized by myocyte
elongation. At these time points the protein is localized to
sites of integrin expression. Using RNAi mediated gene
knockdown, we then examined the function of kindlin-2.
Kindlin-2 was required for differentiation to proceed
through the stage of myoblast fusion. In particular, cells
with reduced levels of kindlin-2 failed to spread and
expand during the developmental phase of myocyte elon-
gation. The myocytes exhibit decreased adhesion to
fibronectin and instead had an increased capacity for
migration. They were also characterized by an abnormal
distribution of integrins and integrin associated proteins.
In particular, the integrin associated protein, integrin
linked kinase (ILK) was redistributed to the membrane
insoluble fraction. In all, our study reveals that the
integrin associated cytoplasmic effector molecule kindlin-
2 is a critical regulator of myogenesis, and implicates
kindlin-2 and integrin junctions in the regulation of myo-
cyte elongation. Further, we propose that kindlin-2 func-
tions by stabilizing and promoting cell-cell adhesion over
cell migration.
Results
Kindlin-2 is enriched during early myogenesis
To study the expression and function of kindlin-2 during
myogenesis, we utilized the well-characterized C2C12 cell
culture model system. Proliferating C2C12 cells resemble
fibroblasts, but upon serum removal they withdraw from
the cell cycle, elongate, and fuse to form multinucleated
myotubes. These stages of differentiation are accom-
plished within the first four days after serum withdrawal,
with myoblast fusion usually beginning by day 3 or 4.
We examined kindlin-2 expression using Western blot
analysis in confluent, proliferating C2C12 cells and dur-
ing the first four days after serum withdrawal-induced
myogenesis (Figure 1). In undifferentiated cells (GM),
kindlin-2 is present at low levels. Upon induction of dif-
ferentiation (DM), kindlin-2 levels rise, peaking at day 3.
At DM3, kindlin-2 expression is approximately 5-fold
higher than in undifferentiated cells. We compared kind-
lin-2 levels with those of the differentiation markers myo-
genin (myog) and myosin heavy chain (MHC). Myogenin
is induced upon cell cycle withdrawal, while MHC is
expressed coincident with the onset of myoblast fusion.
Kindlin-2 levels rise after myogenin but before MHC, at
time points consistent with the myocyte elongation stage
of differentiation.BMC Cell Biology 2008, 9:36 http://www.biomedcentral.com/1471-2121/9/36
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Kindlin-2 localizes to focal contacts and developing 
costameres
We next determined the subcellular localization of kind-
lin-2 during myogenesis using immunohistochemistry. In
undifferentiated C2C12 cells, kindlin-2 expression is faint
but detectable at membrane protrusions and cell-matrix
contacts (Figure 2A; arrowheads). It co-localizes with β1
integrin in a pattern consistent with expression at focal
contacts. The staining in undifferentiated cells is similar to
that reported for kindlin-2 in non-myogenic cell lines.
Upon differentiation, kindlin-2 immunofluorescence
noticeably increases, in agreement with our Western blot
data. In two day differentiated C2C12 cells, kindlin-2 is
highly enriched in puncta along the plasma membrane
(arrowheads, Figure 2B). These puncta also contain β1
integrin, and likely represent areas of cell-cell and cell-
matrix adhesion. In addition, staining is observed along
linear structures within the cell (*). In four day differenti-
ated cells, kindlin-2 is primarily expressed in this linear
staining pattern (Figure 2C). At this structure, it co-local-
izes with β1 integrin and focal adhesion kinase (FAK)
(Figure 2B–C and data not shown). As corroborated by
previously published reports of β1 integrin and FAK
expression patterns[14], this kindlin-2 staining corre-
sponds to the developing costamere. Costameres are
integrin-containing junctions that link sarcomeres to the
plasma membrane[21]. They are believed to represent the
differentiated muscle equivalent of the focal contact. One
additional site of kindlin-2 localization is along the
plasma membrane between adjacent cells (Figure 2D). As
with its expression at other subcellular compartments, it
colocalizes with β1 integrin at these cell-cell contacts.
To support the relevance of the abundant staining of kind-
lin-2 in C2C12 cells, we examined expression in mouse
skeletal muscle (Figure 2E). As with cell culture, anti-kind-
lin-2 strongly stains the sarcolemmal membrane in mus-
cle cross sections and overlaps with the expression of β1
integrin. Kindlin-2 also appears enriched in the perinu-
clear area (**), an organelle rich domain that is enriched
with neuromuscular junctions.
RNAi knockdown of kindlin-2 alters myogenesis
To study the function of kindlin-2 during myogenesis, we
designed synthetic RNAi to the murine kindlin-2 gene.
The extent of knockdown was determined using quantita-
tive RT-PCR (qPCR) (Figure 3A), Western blot analysis
(Figure 3B), and immunohistochemistry (see Figure 6B).
Based on the qPCR data, we consistently observed 70–
80% knockdown 24 hours after RNAi transfection. This
effect was maintained at 3 days after transfection (differ-
entiation day 2), but diminished to approximately 50%
by 5 days (differentiation day 4). The specificity of the
Kindlin-2 expression during myogenesis in vitro Figure 1
Kindlin-2 expression during myogenesis in vitro. Western analysis of kindlin-2 on C2C12 cell protein extracts. C2C12 
cells we cultured in either growth media (GM) or differentiation media (DM) for 1, 2, 3, or 4 days. Kindlin-2 levels were com-
pared to an early (myogenin) and a late (myosin heavy chain; MHC) marker of differentiation. GAPDH was used as a loading 
control. Kindlin-2 expression was induced upon differentiation, with a peak expression at day 3 post-differentiation. Of note, 
the GM cell extract was from confluent cells, and confluence stimulates a small amount of differentiation.BMC Cell Biology 2008, 9:36 http://www.biomedcentral.com/1471-2121/9/36
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Kindlin-2 subcellular localization Figure 2
Kindlin-2 subcellular localization. A.-D. Confocal micrographs of immunohistochemistry using anti-kindlin-2 and anti-β1 
integrin antibodies on undifferentiated (A; GM) C2C12 cells and C2C12 cells induced to differentiate for 2 (B; DM2) or 4 days 
(C, D; DM4). Kindlin-2 co-localizes with β1 integrin at sites of cell-cell and cell-matrix contacts (arrowheads in A, B, and D). 
Kindlin-2 is found at developing costameres at DM2 and DM4 (*). Scale bar = 20 μm. E. Immunostaining of quadriceps muscle 
from a two month-old mouse. Kindlin-2 localizes to the sarcolemmal membrane and is enriched in the perinuclear compart-
ment (**).BMC Cell Biology 2008, 9:36 http://www.biomedcentral.com/1471-2121/9/36
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RNAi for kindlin-2 knockdown and the observed pheno-
typic changes were verified using an independent RNAi
designed to a second part of the gene. Information for
each RNAi is listed in the materials and methods. Of note
is that the homologous gene products kindlin-1 and kind-
lin-3, as determined by RT-PCR, are not expressed in
C2C12 cells under control conditions and are not upreg-
ulated with kindlin-2 knockdown.
We began our analysis of kindlin-2 function by determin-
ing the ability of C2C12s with reduced kindlin-2 levels to
differentiate through the stage of myoblast fusion. We
chose this differentiation end point because it typically
occurs 3–4 days after serum withdrawal, and kindlin-2
levels are highest in the days just prior to it. To measure
myoblast fusion, we calculated the myoblast fusion index
(MFI). The MFI is determined by immunostaining day 4
differentiated cells (DM4) with myosin heavy chain
(MHC), counting the number of nuclei in each MHC pos-
itive cell, and then comparing the number of multinucle-
ated cells to the overall number of MHC positive cells.
Myotubes were considered partially fused if they con-
tained 2–3 nuclei, and fully fused if they contained 4 or
more nuclei. In C2C12 cells transfected with a scrambled
RNAi, 25.5% were partially fused and 23.4% were fully
fused (Figure 4A, B). These data are consistent with previ-
ously published reports on myotube fusion at DM4[22].
In contrast, in C2C12 cells transfected with kindlin-2
RNAi, only 15.4% were partially fused (vs. 25.5%, p =
0.0036) and only 8.9% fully fused (vs. 23.4%, p < 0.0001)
(Figure 4A, B). Overall, while approximately half of all
control/scrambled cells fused, only 25% of cells from
kindlin-2 RNAi transfections were able to differentiate to
the point of even partial fusion, suggesting a delay or
arrest in differentiation prior to or at the stage of myoblast
fusion.
To confirm that kindlin-2 RNAi significantly hindered
myogenesis, we measured the levels of various markers of
differentiation using both qPCR and Western blot analy-
sis. We examined myosin heavy chain isoform 8 (myh8)
and myotilin RNA levels at differentiation day 4 using
qPCR. Both genes are expressed starting at the stage of
myoblast fusion. As expected from our myotube fusion
data, both myh8 and myotilin levels were substantially
lower in kindlin-2 RNAi transfected cells as compared to
scrambled RNAi transfected cells (Figure 5A). We utilized
Western analysis of myosin heavy chain to substantiate
our RNA data. As shown in Figure 5B, MHC protein levels
are also diminished at differentiation day 4. Myogenin
protein levels were also examined, and were undistin-
guishable between scrambled and kindlin-2 RNAi sam-
ples. This suggests that differentiation proceeds through
the point of myogenin induction, but is altered prior to
later events like fusion.
To address if differentiation is simply delayed as opposed
to arrested, we examined cultures incubated for 6 days in
RNAi reduces kindlin-2 levels Figure 3
RNAi reduces kindlin-2 levels. A. Quantitative PCR analysis of C2C12 cells treated with kindlin-2 or scrambled siRNA. 
Samples for analysis were collected 1 day (GM), 3 days (DM day 2) and 5 days (DM day 4) after transfection. Relative kindlin-2 
levels were (si scrambled vs. si mig2): 33% vs. 8% (GM), 100% vs. 28% (DM day 2), and 83% vs. 36% (DM day 4). Numbers 
reflect percent level as compared to scrambled RNAi at DM day 2. Values were averaged from 4 independent transfections, 
each analyzed in triplicate. B. Immunoblot of kindlin-2 on protein extracts obtained after 2 days in DM (72 hrs after transfec-
tion). A band corresponding to kindlin-2 (arrow) is observed in the scrambled RNAi lane only. Equal loading was confirmed by 
reprobing the blot with S6 kinase (S6K) and GAPDH (data not shown).BMC Cell Biology 2008, 9:36 http://www.biomedcentral.com/1471-2121/9/36
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Myocyte elongation is impaired by kindlin-2 knockdown Figure 6
Myocyte elongation is impaired by kindlin-2 knockdown. A. C2C12 cells were transfected with RNAi and either main-
tained in Growth Media (GM) or changed to Differentiation Media for two days (DM D2). Cellular area was determined using 
Metamorph on immunostained cells overexposed to reveal their cell borders. There was a small but significant difference 
between conditions in undifferentiated cells (kindlin-2 RNAi vs. scrambled RNAi: 7692 +/- 172 pixels v 9080 +/- 348 pixels, n= 
240 cells, p = 0.006). There was a substantial difference between conditions in differentiated cells (kindlin-2 RNAi vs. scrambled 
RNAi: 7510 +/- 599 pixels v 13180 +/- 906 pixels, n = 270, p = 0.001). B. C2C12 cells at differentiation day 2 immunostained 
with anti-kindlin-2. The photomicrographs emphasize the obvious size difference between scrambled RNAi transfected cells 
and those transfected with kindlin-2 RNAi. They also reinforce the successful knockdown of kindlin-2 protein by RNAi. (scale 
bar = 20 μm).BMC Cell Biology 2008, 9:36 http://www.biomedcentral.com/1471-2121/9/36
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Myoblast fusion and kindlin-2 knockdown Figure 4
Myoblast fusion and kindlin-2 knockdown. A. C2C12 cells transfected with scrambled (scr) or kindlin-2 RNAi, incubated 
in differentiation media for 4 days, and then immunostained with anti-myosin heavy chain. Note that most MHC positive myob-
lasts treated with kindlin-2 RNAi do not form elongated, multinucleated myotubes. B. Myotube Fusion Index (MFI). The MFI 
was calculated using immunostained cells as in (A). The number of nuclei (labeled with DAPI) were counted in each MHC pos-
itive cell. There were significantly fewer fused myotubes in kindlin-2 knockdown cells. Results were (scrambled vs. kindlin-2): 1 
nuclei 51.1+/-2.9% vs. 75.6+/-2.6% (p = 0.0001); 2–3 nuclei 25.5+/-2.6% vs. 15.4+/-1.0% (p = 0.0036); >3 nuclei 23.4+/-1.3% vs. 
8.9+/-1.6% (p < 0.0001). Counts were obtained from 5 independent trials/transfections, and at least 250 cells from each condi-
tion were counted per trial.BMC Cell Biology 2008, 9:36 http://www.biomedcentral.com/1471-2121/9/36
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differentiation media. At this time point, because our
RNAi is delivered via transient transfection, kindlin-2 lev-
els are recovered to greater than 50% of normal (data not
shown). Despite this, there continues to be a reduction in
the number of fused myotubes (Figure 5C). In addition,
as determined by Western blot analysis, there are reduced
levels of the late differentiation marker β1D integrin (Fig-
ure 5D). These data suggest an arrest of myogenesis prior
to the stage of myoblast fusion.
Kindlin-2 knockdown prevents myoblast elongation
A key event during in vitro differentiation is myocyte elon-
gation[22]. Elongation directly precedes myoblast fusion.
Given that integrin adhesion is implicated in the elonga-
tion process, we next examined the extent to which RNAi
transfected cells increased in cellular volume after differ-
entiation. We accomplished this by measuring the two-
dimensional attached area of cells just prior to differenti-
ation and then two days after induction of differentiation.
Undifferentiated C2C12 cells transfected with kindlin-2
RNAi, while phenotypically normal in appearance, had
Altered expression of differentiation markers and kindlin-2 knockdown Figure 5
Altered expression of differentiation markers and kindlin-2 knockdown. A. Relative RNA levels of myh8 and myotilin 
in RNAi transfected, 4 day differentiated C2C12 cells as determined by qPCR. Each value was calculated from 3 independent 
transfections with qPCR performed in triplicate. In kindlin-2 RNAi transfected cells, myh8 and myotilin levels were 58 +/-1% 
and 56+/-3%, respectively, of the values obtained for control cells. B. Immunoblot on protein extracted from day 4 differenti-
ated samples transfected with scrambled or kindlin-2 RNAi. Blots were probed with the following antibodies: myogenin 
(myog), myosin heavy chain (MHC), and GAPDH (loading control). Densitometric analysis revealed no difference in myogenin 
levels between samples, and a reduction to 75% of normal for MHC. C. Brightfield images of scrambled (scr) or kindlin-2 
(kind2) RNAi transfected C2C12 cells incubated in differentiation media for 6 days (DM D6). Note extensive myotube forma-
tion in the scrambled sample as compared to the kindlin-2 RNAi sample. D. Immunoblot of day 4 (DM D4) and day 6 (DM D6) 
differentiated myocytes transfected with scrambled (scr) or kindlin-2 (kind2) RNAi. Blots were probed with antibodies to β1D 
integrin and GAPDH. Densitometric analysis revealed 75% and 77% reductions respectively in β1D integrin levels in kindlin-2 
RNAi samples.BMC Cell Biology 2008, 9:36 http://www.biomedcentral.com/1471-2121/9/36
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slightly less attached area than controls (7,000 pixels vs.
8,000 pixels; Figure 6A). Upon differentiation, however,
there was a dramatic difference in calculated areas. Cells
transfected with scrambled RNAi increased to 14,000 pix-
els by differentiation day 2, while kindlin-2 RNAi treated
cells only increased to 8,000 pixels (Figure 6A). This sta-
tistical difference was also apparent by visual inspection
and on cells immunostained with various antibodies. One
example is depicted in Figure 6B, which shows D2 differ-
entiated cells stained with anti-kindlin-2. As compared to
cells transfected with scrambled siRNA (left panel), the
cells with reduced levels of kindlin-2 were clearly smaller
and had a non-extended morphology (right panel). In all,
these data indicated that reduction of kindlin-2 levels
resulted in a failure of myocyte elongation.
Kindlin-2 knockdown alters cell spreading and cell 
migration
To better understand the reason myocytes with reduced
kindlin-2 levels do not properly elongate, we measured
their ability to spread/adhere to different extracellular
matrices and also to migrate through transwell chambers.
Cells were transfected with RNAi, differentiated for 2 days
by serum withdrawal, and then trypsinized in preparation
for the relevant assays.
To study cell adhesion, cells were replated onto plastic,
fibronectin, laminin-1 and collagen IV. After replating for
one hour onto plastic dishes, 75% of control cells adhered
and spread. Conversely, only 42% of kindlin-2 RNAi cells
spread (Figure 7A, p < 0.0001, n = 5 trials). A similar
decrease in spreading was observed with laminin and col-
lagen IV coated dishes (data not shown). Replating on
fibronectin, however, produced a much more dramatic
difference. At one hour, 94% of control cells spread on
fibronectin dishes, an expected increase over plastic dishes
given that α5β1, a fibronectin receptor, is the predomi-
nant integrin heterodimer expressed at differentiation day
2[23,24] (Figure 7A). On the other hand, only 47% of
kindlin-2 RNAi transfectants spread on this surface, a
value only marginally higher than that recorded for plastic
dishes (Figure 7A, p < 0.0001, n = 5 trials). Representative
RNAi transfected cells replated onto fibronectin are
shown in Figure 7B.
We then examined whether cell motility was also affected
by kindlin-2 knockdown. To test migration, siRNA trans-
fected cells were replated onto the upper surface of tran-
swell chambers. Using crystal violet staining as an
indicator of cell number, we measured the number of cells
which migrated through to the bottom of the transwell
after 24 hours. We observed a substantial difference
between conditions, with significantly more cell migra-
tion detected in chambers with cells exposed to kindlin-2
RNAi (Figure 7C). This finding demonstrates that loss of
kindlin-2 has a pro-migratory effect on C2C12 cells.
When considered with our observation that kindlin-2
deficient myoblasts fail to properly elongate and have
altered substratum adhesion, it suggests that kindlin-2 is
critical for the transition of C2C12 cells from a motile
state to a strongly adhered, elongated state.
Given these changes in cell adhesion and cell motility,
and in particular the changes observed with spreading on
fibronectin, we examined the possibility that kindlin-2
knockdown affected extracellular matrix protein or
integrin receptor expression. Using a combination of RT-
PCR, real time PCR, and Western blot analysis, we
detected no difference in the RNA or protein levels of
fibronectin, laminin and merosin, and no alteration of
RNA levels of α5 or α7 integrins (data not shown).
Kindlin-2 knockdown alters ILK localization
In C. elegans, unc-112, the worm homolog of kindlin-2,
binds to and modulates the function of Pat-4, the worm
homolog of ILK[25]. Because ILK is required for mamma-
lian myogenesis both in vivo and in vitro, we wanted to
establish the effect of kindlin-2 knockdown on ILK expres-
sion and localization. At differentiation days 2 and 4, the
overall levels of ILK were unchanged between conditions
(Figure 8A), yet the localization of ILK was significantly
altered. As determined using subcellular fractionation,
essentially all ILK in control transfected cells was present
in the cytosolic fraction at differentiation day 2 (Figure
8B). This is consistent with previously published reports
on ILK localization in C2C12 cells[12]. In contrast, ILK
was found only in the membrane/insoluble fraction in the
kindlin-2 knockdown myocytes (Figure 8B). Thus, in the
absence of kindlin-2, ILK fails to redistribute to its proper
cytosolic localization during myogenesis.
Kindlin-2 knockdown affects focal contact distribution
We next examined other focal contact components for
similar changes in subcellular localization. In control
transfected cells at differentiation day 2, we observed the
expected pattern of expression for β1 integrin and paxillin
both in discrete points along the membrane as well as in
linear structures throughout the cells (Figure 9A). In kind-
lin-2 RNAi transfected cells, we detected a relative shift in
this distribution, with concentration of the staining in
punctate at the sarcolemmal membrane. Of note is that
we did not see obvious changes in the subcellular locali-
zation of FAK or migfilin (data not shown).
We also measured F-actin staining using Oregon Green
conjugated phalloidin. We again observed a qualitative
redistribution of F-actin from a linear pattern in control
myocytes to concentration along the sarcolemmal mem-
brane in kindlin-2 RNAi myocytes (Figure 9B). Taken
together with our ILK results, these data suggest thatBMC Cell Biology 2008, 9:36 http://www.biomedcentral.com/1471-2121/9/36
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Kindlin-2 knockdown alters C2C12 adhesion and migration Figure 7
Kindlin-2 knockdown alters C2C12 adhesion and migration. A. Day 2 differentiated myocytes were plated onto either 
non coated or fibronectin coated cell culture dishes and incubated for 1 hour at 370C. Cells were fixed and then examined for 
morphologic changes consistent with adhesion and spreading. On non coated dishes, percent spreading was 71.6% (+/-0.02%) 
for scrambled and 41.8% (+/-0.03%) for kindlin-2 RNAi (p < 0.0001, n = 5). On fibronectin, percent spreading was 93. 8% (+/-
0.01%) for scrambled and 47.2% (+/-0.03) for kindlin-2 RNAi (P < 0.0001, n = 5). B. Bright field photomicrograph taken at 10× 
of representative cells from the assay described in A. The arrow points to a spread cell while the arrowhead points to a non-
spread cell in kindlin-2 RNAi transfectents. C. RNAi transfected C2C12 cells were replated onto transwell and allowed to 
migrate through the wells to a lower chamber filled with media. Migrated cells were counted after 12 hours. Significantly more 
migration was observed with kindlin-2 knockdown (scrambled v kindlin-2 RNAi, 0.11+/-0.01 v 0.16+/-0.01; p = 0.019; n = 3).BMC Cell Biology 2008, 9:36 http://www.biomedcentral.com/1471-2121/9/36
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integrin based, ILK-containing adherens junctions are
inappropriately distributed in differentiating myocytes.
We hypothesize that, in the absence of kindlin-2, ILK
enriched focal adhesions fail to redistribute into an exten-
sive linear pattern during myogenesis, and that this in
turn results in defective myocyte elongation (Figure 10).
Discussion
C2C12 cells undergo a well-documented series of steps
after induction of differentiation by serum with-
drawal[22]. Within 24 hours, cells exit the cell cycle and
begin expressing muscle specific transcription factors. The
next stage is myocyte elongation, where dramatic changes
in cell morphology occur between 1 and 3 days after
induction. Elongation is followed by myoblast fusion,
which begins at differentiation day 3. In this study, we
describe for the first time the role of kindlin-2 in these
early stages of differentiation. In particular, we identify
kindlin-2 as a novel integrin associated cytoplasmic adap-
tor protein important for the process of myocyte elonga-
tion.
Myocyte elongation, while a well-described morphologic
phenomenon, is not well characterized at the molecular
level. As revealed by two published studies, integrin sign-
aling has been previously implicated in the process. In the
first, alteration of integrin binding to the extracellular
matrix by manipulation of matrix metalloprotease func-
tion in C2C12 cells causes abnormalities in myocyte elon-
gation[22]. In the second study, overexpression of the
focal contact associated protein FHL1/SLIM induces
hyper-elongation, with the hyper-elongation dependent
on integrin-ligand binding[26]. Our study clearly sup-
ports and advances this association between integrin junc-
tions and myocyte elongation. Furthermore, it introduces
kindlin-2 as one of the key molecular regulators of the
process.
How might kindlin-2 regulate elongation? Our hypothe-
sis is that kindlin-2 promotes and stabilizes cell adhe-
sions. This hypothesis is supported by several
observations. The first is differentiating myocytes with
reduced kindlin-2 expression have impaired spreading on
all extracellular matrix surfaces and in particular on
fibronectin. The second is that kindlin-2 expression
appears to reduce the motile behavior of myocytes. This
effect of cell migration has been previously demonstrated
for kindlin-2 in a series of non-myogenic tumor cell
lines[15]. Specifically, Wu and colleagues showed an
inverse correlation between tumor cell motility and kind-
lin-2 levels, and additionally showed that expression of
kindlin-2 in motile cell lines decreased their migration
and strengthened their attachments. The third, as
described in our previous study, is that loss of kindlin-2 in
zebrafish muscle leads to less elaborate cell-cell junctions
ILK localization is altered with kindlin-2 knockdown Figure 8
ILK localization is altered with kindlin-2 knockdown. 
A. Immunoblot on protein from C2C12 cells at differentia-
tion day 2 (D2) and day 4 (D4) transfected with scrambled 
(scr) or kindlin-2 (kind2) RNAi. Blots were probed with anti-
ILK and anti-GAPDH. No difference by densitometry was 
detected between scrambled and kindlin-2 RNAi cells. Dot 
indicates ILK band. B. Immunoblot on subcellular fractions 
from day 2 differentiated C2C12 cells probed with anti-ILK. 
ILK localizes to the cytosolic (cyto) fraction in scrambled 
RNAi cells and to the membrane/insoluble (mem) fraction in 
kindlin-2 RNAi cells. No expression was seen with either 
condition in the cytoskeletal or nuclear fractions (data not 
shown).BMC Cell Biology 2008, 9:36 http://www.biomedcentral.com/1471-2121/9/36
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Kindlin-2 knockdown and focal adhesion localization Figure 9
Kindlin-2 knockdown and focal adhesion localization. A. Confocal immunofluorescent microscopy with anti-β1 integrin 
(green) and anti-paxillin (red) on C2C12 cells transfected with RNAi and then changed to differentiation media for 2 days. 
Control cells (scr RNAi) show linear staining consistent with localization to costameres (arrows), as well as punctate focal con-
tact staining (arrowheads). Conversely, focal contact proteins in the kindlin-2 RNAi cells fail to form linear structures and 
instead are concentrated in unusual appearing puncta (*). (Scale bar = 20 μM). B. Oregon Green phalloidin staining on day 2 dif-
ferentiated C2C12 cells. In the scrambled RNAi myocytes, actin is found primarily in a linear, fiber like pattern. Conversely, in 
the kindlin-2 RNAi cells it is found concentrated at the membrane. (Scale bar = 20 μM).BMC Cell Biology 2008, 9:36 http://www.biomedcentral.com/1471-2121/9/36
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which, by ultrastructural analysis, do not have their typi-
cal associations with the underlying cytoskeleton[20]. In
addition, we reported that both cardiac muscle and skele-
tal muscle in the fish are smaller in the absence of kindlin-
2. The data from the present study suggest that this may be
on the basis of failed myocyte elongation.
Understanding how precisely kindlin-2 stabilizes adhe-
sion and promotes myocyte elongation is an open ques-
tion deserving further study. Our data support a potential
role for ILK in this process. Previous work on ILK, while
clearly showing a requirement for the gene for both car-
diac and skeletal myogenesis[11,12,27], has not specifi-
cally implicated the protein in myocyte elongation.
However, ILK is associated both with the stabilization of
adhesion and with the promotion of migration[28,29].
Participation in these seemingly paradoxical activities
depends on ILK kinase activity, ILK localization and dif-
ferential association with ILK binding partners. As known
binding partners, kindlin-2 and ILK are logical candidates
to share functions[25]. Similar to observations from C.
elegans, we describe here altered localization of ILK with
the reduction of kindlin-2 expression. Because ILK locali-
zation is a significant factor in whether it functions to pro-
mote adhesion or migration, a plausible mechanism for
kindlin-2 function is that it localizes to integrin junctions
Schematic of kindlin-2 function during early myogenesis Figure 10
Schematic of kindlin-2 function during early myogenesis. A. Undifferentiated C2C12 cells with typical fibroblast-like 
morphology B. Upon change to differentiation media, control cells withdraw from the cell cycle and elongate. In cells with 
reduced levels of kindlin-2, cells fail to elongate, and instead maintain a "pro-migratory" phenotype. C. By differentiation day 4, 
elongated control cells fuse into multinucleated myotubes. Reduced levels of kindlin-2 result in failure of myotube formation, 
likely as a result of decreased elongation, inadequate cell adhesion and impaired myoblast fusion. One mechanism underlying 
these alterations is a failure of redistribution of ILK containing focal adhesions.BMC Cell Biology 2008, 9:36 http://www.biomedcentral.com/1471-2121/9/36
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in the differentiating myocyte and it in turn stabilizes ILK
association with these junctions. This interaction then
promotes adhesion and stimulates elongation, likely via
actin cytoskeletal remodeling. Loss of kindlin-2 would
then be expected to cause improper localization of ILK,
potentially to sites that promote migration.
Regardless of the exact mechanism, the suggestion from
our data that kindlin-2 is involved with ILK regulation is
important in reference to human muscle disease. ILK has
been both directly and indirectly implicated in cardiac
hypertrophy[30], cardiomyopathy[31,32] and muscular
dystrophy[11]. An association of kindlin-2 with ILK thus
strengthens the hypothesis that kindlin-2 is likely to be
important for human muscle diseases.
It is quite likely, however, that kindlin-2 function is trans-
mitted in part by additional regulatory proteins. One
intriguing molecule is FHL1, a LIM domain containing
protein. Currently, other than β1 integrin, the only well-
established binding partner for kindlin-2 is migfilin,
which is also a LIM domain protein[16]. We did not
observe alterations in migfilin expression, and migfilin
has yet to be associated with skeletal myogenesis. Thus
one possibility may be that kindlin-2 regulates elongation
by recruiting FHL1 to integrin junctions. This hypothesis
is of clinical relevance, as FHL1 mutations have been
detected in patients with an X-linked muscle disease
called Scapulo-Peroneal Syndrome[33,34]. Another pos-
sibility is that kindlin-2 facilitates and stabilizes the asso-
ciation between integrin junctions and the underlying
actin cytoskeleton. Such a role is supported by the func-
tion of its C. elegans homolog unc-112 and by our previ-
ous published data from the zebrafish[19,20].
An additional event in myogenesis that may require kind-
lin-2 function is myoblast fusion. Integrin junctions have
a well established association with fusion[7], and kindlin-
2 is expressed at the correct development time (3–4 days
after induction of differentiation) and in the correct loca-
tion (co-localized with integrin at sites of cell-cell attach-
ment). We clearly observe a defect in the ability of
kindlin-2 RNAi transfected cells to proceed through the
stage of myoblast fusion. Alternatively, this observation
may be explained by the fact that these myocytes have
defective elongation, and elongation may be required for
fusion to proceed. Further experimentation is thus neces-
sary to resolve this potential function.
Conclusion
In summary, we have demonstrated that kindlin-2 is a
critical regulator of early myogenesis in vitro. Its specific
functions in myocyte elongation suggest it is a novel reg-
ulator of integrin signaling during myogenesis. Based on
its expression and function, kindlin-2 represents a poten-
tially important factor in integrin-related human muscle
pathologies, especially the muscular dystrophies.
Methods
Tissue culture
C2C12 cells were obtained from ATCC. They were main-
tained in growth media (GM; DMEM (Gibco) + 10% FBS
(HyClone)) and differentiated in differentiation media
(DM; DMEM + 2% Horse Serum (HyClone)). Cells were
grown on 60 mm plastic ware (Falcon) or on 22 mm cov-
erglass coated with Fibronectin (BD Biosciences). All
transfections were done with Lipofectamine 2000 (Invit-
rogen). RNAi specific for mouse Kindlin-2 was obtained
from Invitrogen (oligo IDs MSS211904/5). Stealth Nega-
tive Control Medium was used as the scrambled control
(Invitrogen). Transfection efficiency of the RNAi was >
90%, as determined by co-transfection with the BLOCK-iT
reagent (FITC conjugated; Invitrogen).
Immunofluorescence
Immunofluorescence microscopy was performed on
C2C12 cells and cryosections from fresh frozen adult
mouse quadriceps using standard methodology. Cells
were fixed for 10 minutes at 4°C in 1:1 methanol:acetone
or at room temperature in 4% paraformaldehyde and tis-
sue sections were fixed for 5 minutes at room temperature
in acetone. The following primary antibodies were used:
goat anti-Kindlin-2 (1:25; Santa Cruz); mouse anti-kind-
lin-2 (1:30; Abnova); mouse anti-paxillin (1:300; Trans-
duction Laboratories); anti-β1 integrin-FITC (1:100; Santa
Cruz); rat anti-β1 integrin (1:25; Chemicon); mouse anti-
myosin heavy chain (MF20; 1:30; Developmental Hybri-
doma Bank), and Oregon Green phalloidin (1:200; Invit-
rogen). Alexafluor-conjugated secondary antibodies were
used at 1:250 (Invitrogen). Nuclei were counterstained
with ProLong Gold plus DAPI (Invitrogen). Analysis was
performed with an Olympus FluoView 500 laser scanning
confocal microscope. Samples were scanned on an Olym-
pus IX-71 inverted confocal microscope using either a 60×
or 100× oil immersion objective and captured using the
FluoView v4.3 software.
Immunoblots
Protein was extracted from C2C12 cell cultures using RIPA
buffer with Complete Protease Inhibitors (Roche). Sam-
ples were quantitated using the Bradford assay (Pierce).
40 μg or 70 μg (for kindlin-2) of extract was resolved by
SDS-PAGE, transferred to Immobilon (Millipore), and
subjected to immunoblotting. Membranes were blocked
for 1 hour with 5% milk in PBS containing 0.1% Tween.
Membranes were incubated in primary and secondary
antibodies for 1 hour at room temperature. Primary anti-
bodies used were: mouse anti-kindlin-2 (1:250); mouse
anti-GAPDH (1:1000); rabbit anti-myogenin (1:1000;
abcam); mouse anti-MHC (1:1000); rabbit anti-ILKBMC Cell Biology 2008, 9:36 http://www.biomedcentral.com/1471-2121/9/36
Page 15 of 16
(page number not for citation purposes)
(1:1000; Millipore); rabbit anti-FAK (1:2000; Santa Cruz);
rabbit anti-laminin (1:2000; Sigma); rabbit anti-fibronec-
tin (1:200; Santa Cruz); β1D integrin (1:1000; Chemi-
con). Secondary antibodies were from Santa Cruz
Biotechnology and used at 1:2000. Blots were developed
using Lumiglo (Cell Signalling) and exposed to Hyperfilm
(GE Biosciences). Protein extracts for cell fractionation
studies were obtained using the Qproteome Cell Com-
partment kit (Qiagen). Successful fractionation was veri-
fied using the following antibodies: nuclei and membrane
(insoluble)- emerin (1:1000; Abcam), cytoplasmic-
GAPDH, cytoskeletal- actin (1:200, Santa Cruz).
Real time PCR
RNA was extracted from C2C12 cell cultures using the Tri-
zol reagent (Invitrogen). First strand cDNA was synthe-
sized from 1 μg RNA using the Promega Reverse
Transcription System with the Random Hexamer Primer.
cDNA was diluted 1:10, and then 2 μL was used for Real
Time PCR. Real Time PCR was performed using the
QuantiTect SYBR-Green reagent and iCycler iQ PCR
machine (Qiagen). Real Time primers were obtained from
Qiagen. GAPDH was used as the amplification control.
Cell size determination
Immunofluorescence using anti-β1 integrin FITC was per-
formed on RNAi transfected C2C12 cells incubated in
either growth media or differentiation media. Fluores-
cence was visualized at 20× using a Nikon Microphot
Microscope. Digital images were obtained in MetaMorph
using SPOT camera. Cell size was determined for mono-
nuclear cells in MetaMorph with the free hand tool and
area determination calculator. Cell areas were then ana-
lyzed and histograms generated using Prism. Single-tailed
Student's t-test was used to determine statistical signifi-
cance.
Myoblast fusion index
Immunofluorescence using anti-MHC was performed on
C2C12 cells at 4 days after differentiation. Nuclei were
counterstained with DAPI. Digital images were captured
at 20× as done above for cell size determination. The
Myoblast Fusion Index was calculated as follows: MHC-
positive cells were scored as having 1, 2–3, or >3 nuclei.
Values were expressed as a percentage of the total number
of MHC-positive cells counted. At least 250 cells were
counted for each condition, and 4 separate trials were per-
formed. Values were analyzed and histograms generated
using Prism, and statistical significance determined using
a single-tailed t-test.
Myocyte adhesion assay
RNAi transfected C2C12 cells at differentiation day 2 were
dissociated with trypsin and then replated onto 60 mM
culture dishes. Dishes either had no coating or were pre-
coated with laminin-1, collagen IV, or fibronectin (Bectin
Dickinson). Cells were allowed to adhere for 60 minutes
at 37°C in differentiation media, and then were fixed for
10 minutes at room temperature in 4% paraformalde-
hyde. Cells were examined with an inverted microscope at
20× magnification and scored as adhered if they assumed
a spread morphology and non adhered/spread if they had
a rounded morphology with no processes. 5 counts of at
least 25 cells were performed for each condition.
Myocyte migration assay
RNAi transfected C2C12 cells were dissociated with Dis-
sociation solution (Sigma), counted with a hemocytome-
ter, and plated on top of transwells (1 × 105 cells/well).
Cells were incubated for 12 hours in DMEM/2%HS. Tran-
swells (Costar) were then processed as follows: Cells were
removed from inner wells with Q-tips. Outer wells were
stained with crystal violet for 20 minutes, eluted with 10%
acetic acid, and then measured on a plate reader at 590
nm.
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